Kura Oncology, Inc. KURA
- KOMZIFTI — Acute Myeloid Leukemia Approved
NPM1 (2 companies · 2 programs)
Companies with an active program directed at NPM1.
Syndax Pharmaceuticals Inc SNDX
- Revuforj — Relapsed/Refractory Acute Myeloid Leukemia with NPM1 Mutation Approved